- Home
- VINP vs MDXG Comparison
VINP vs MDXG Comparison
Compare VINP & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VINP | MDXG |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 638.8M | 625.6M |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | VINP | MDXG |
|---|---|---|
| Price | $10.05 | $4.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $14.00 | $9.00 |
| AVG Volume (30 Days) | 25.9K | ★ 1.5M |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | ★ 5.72% | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | $18.07 | N/A |
| Revenue Next Year | $12.74 | $13.02 |
| P/E Ratio | $24.41 | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $9.29 | $3.03 |
| 52 Week High | $13.61 | $7.97 |
Technical Indicators
Market Signals| Indicator | VINP | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 53.70 | 51.89 |
| Support Level | $9.87 | $4.09 |
| Resistance Level | $10.28 | $4.45 |
| Average True Range (ATR) | 0.24 | 0.20 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 86.67 | 57.93 |
Price Performance
Historical ComparisonAbout VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.